Navigation Links

Biology Technology

Largest genetic survey to date shows major success of giant panda breeding programs

7/23/2014
Heroic worldwide conservation efforts have made great strides in saving China's endangered national treasure, the giant panda. Now, in China, there are over 65 giant panda reserves that have been established and three large breeding centers. But despite these efforts, just 1596 pandas remain in the wild. Breeding programs in conservation centers and zoos hope to save the panda by improvin... [Comments]

Scientists find way to maintain quantum entanglement in amplified signals

7/23/2014
Physicists Sergei Filippov (MIPT and Russian Quantum Center at Skolkovo) and Mario Ziman (Masaryk University in Brno, Czech Republic, and the Institute of Physics in Bratislava, Slovakia) have found a way to preserve quantum entanglement of particles passing through an amplifier and, conve... [Comments]Scientists find way to maintain quantum entanglement in amplified signals

A crystal wedding in the nanocosmos

7/23/2014
Researchers at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR), the Vienna University of Technology and the Maria Curie-Skłodowska University Lublin have succeeded in embedding nearly perfect semiconductor crystals into a silicon nanowire. With this new method of producing hybrid nano... [Comments]A crystal wedding in the nanocosmos

truBrain Neuroscientists To Launch More Effective, Healthier Alternative To Energy Drinks On Indiegogo

7/23/2014
LOS ANGELES , July 23, 2014 /PRNewswire-iReach/ -- Think Drinks are a neuroscience-backed drink regimen developed to enhance cognitive performance for the long term. They are the first functional focus beverage to give users the competitive edge of sustained energy as an alternative to the temporary fix associated with energy drinks. truBrain will launch Think Drinks on Indiegogo on July 29,... [Comments]

AuraSense Therapeutics Appoints Biotechnology Veteran David S. Snyder as Chief Financial Officer

7/23/2014
SKOKIE, Ill. , July 23, 2014  AuraSense Therapeutics, the pioneer in developing spherical nucleic acid (SNA™) constructs as gene regulatory and immunotherapeutic agents, announced today that David Snyder has joined AuraSense Therapeutics' executive leadership team as chief financial officer effective July 11. Prior to joining AuraSense Therapeutics, Mr.... [Comments]

Shimadzu's New UF-Amino Station Provides High-Speed, Multi-Component Analysis of Amino Acids in Food & Beverage and Pharmaceutical Testing

7/23/2014
Columbia, MD (PRWEB) July 23, 2014 Shimadzu Scientific Instruments has launched the UF-Amino Station, an LC/MS amino acid analysis system developed jointly with Ajinomoto Co. Inc. Offering simultaneous multicomponent analysis, the UF-Amino Station can analyze 38 amino acids in nine minutes, drastically enhancing laboratory throughput. The UF-Amino Station achieves high-speed analysis uti... [Comments]

Formedix and OmniComm Systems® Partnership Strengthened with the Release of Enhanced TrialMaster® Integration for EDC Build

7/23/2014
(PRWEB) July 23, 2014 Last year, Formedix celebrated its partnership with OmniComm Systems , a leading global provider of data management solutions for clinical trials. The company launched its integration with TrialMaster, a leading-edge system for electronic data capture (EDC) and clinical data management. Formedix, a renowned provider of universal design and study execution tools adde... [Comments]

MSC and Cape Regional Medical Center Partner to Improve Cost, Quality and Outcomes

7/23/2014
DENVER , July 23, 2014  Having the right people at the table for significant business decision making is vital to accelerating business growth and achieving clinical and operational goals. The 22 nd Annual American Hospital Association (AHA) Leadership Summit, July 20-22, 2014, in San Diego , featured a prestigious panel of hospital executives and healthcare experts di... [Comments]

ADB International Group Inc. anuncia una asociación con Austen BioInnovation Institute

7/23/2014
SAN ANTONIO , 23 de julio de 2014 ADB International Group Inc.: OTCQB: ADBI (ADBI o la Compañía) ha anunciado hoy una asociación con Austen BioInnovation Institute en Akron (ABIA o el Instituto), para el propósito de llevar el E-QURE BST™ de ADBI, un dispositivo de terapia de señal bioeléctrica (el E-QURE BST Device), al mercado estadoun... [Comments]

StemGenex® Gives Hope to Parkinson’s Patients through New Stem Cell Clinical Study

7/23/2014
La Jolla, CA (PRWEB) July 23, 2014 StemGenex® , the leading resource for adult adipose stem cell therapy in the US aimed at improving the lives of patients dealing with degenerative diseases today announced their newest clinical study for Parkinson’s disease. StemGenex believes that a commitment to the safety and efficacy of stem cell therapy are paramount when providing care to pati... [Comments]

Valentis Nanotech Signs MOU to Integrate Technology in Thermoplastics Production

7/23/2014
TEL AVIV, Israel , July 23, 2014 - Valentis Nanotech Ltd ., a portfolio company of Trendlines Agtech , announced it has signed an MOU with one of Israel's leading agricultural thermoplastics applications companies.      (Logo: http://photos.prnewswire.com/prnh/20140121/666259-a) Valentis's technology combines nanocrystalline cellulose (NCC), a... [Comments]

Medicine Technology

Eric T. Converse Named President And Chief Executive Officer Of VirtualScopics, Inc.

7/23/2014
ROCHESTER, N.Y. , July 23, 2014 The Board of Directors of VirtualScopics, Inc. (NASDAQ: VSCP ), a leading provider of clinical trial imaging solutions, announced today that Eric T. Converse , 48, has been named president and chief executive officer, effective immediately.  Mr. Converse joined the company's Board of Directors in August 2013 and has held the positions of... [Comments]

Sensor Market in Consumer Healthcare (Patient Monitoring, Therapeutic, Handheld and Homecare, & Fitness and wellness) - Analysis & Forecast to to 2013 - 2020

7/23/2014
DUBLIN , July 23, 2014 Research and Markets has announced the addition of the "Sensor Market in Consumer Healthcare by Application, Sensor Type & by Geography - Analysis & Forecast to to 2013 - 2020" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 There has been an increasing momentum for consumer healthcare monitoring and sensin... [Comments]

SURPASS Launches New Company Logo and Corporate Website, Symbolizing Transformation of Company Culture to Meet the Changing Needs of Clients in the Life Science Community Today.

7/23/2014
OSCEOLA, Wis. and MOUNTAIN VIEW, Calif. , July 23, 2014 /PRNewswire-iReach/ -- Surpass, Inc. ("Surpass"), a recognized leader in translational preclinical research, today unveiled their new logo and corporate website (found at www.surpassinc.com ), signaling the transformation of Surpass' corporate culture to one where our team is an integrated innovation partner for our customers. This... [Comments]

Global Diagnostic Electrocardiograph (Resting, Stress, Holter Monitor) (ECG) Market - Forecast to 2020

7/23/2014
DUBLIN , July 23, 2014 Research and Markets  has announced the addition of the "Diagnostic Electrocardiograph (ECG) Market by Product, End-user & by Lead Type - Global Forecast to 2020" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 The global diagnostic electrocardiograph (ECG) market is segmented into three major segments, nam... [Comments]

Pharmavite Appoints Timothy Toll Chief Customer Officer

7/23/2014
NORTHRIDGE, Calif. , July 23, 2014 Pharmavite LLC announced that Timothy "Tim" Toll has been named the company's chief customer officer effective immediately. Toll recently served as Pharmavite's executive vice president of sales, overseeing customer sales and marketing, category management, private label and sales administration in the United States . In his new global rol... [Comments]

AbbVie to Host Second-Quarter Earnings Conference Call

7/23/2014
NORTH CHICAGO, Ill. , July 23, 2014 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION. AbbVie (NYSE: ABBV ) will announce its second-quarter 2014 financial results on Friday, July 25, 2014, before... [Comments]

Eclipse Aesthetics, LLC Files Suit Against RegenLab USA, LLC

7/23/2014
DALLAS , July 23, 2014 On Tuesday, July 1, 2014, Eclipse Aesthetics, LLC ("Plaintiff") filed suit in the 116 th Judicial District Court in Dallas, Texas , against RegenLab USA, LLC ("Defendant") for Tortious Interference with Current and Prospective Business Relationships through false and misleading actions, fraud, fraud-in-the-inducement, business interference, tor... [Comments]

Announcing a New Regional Approach to Medicare Quality Improvement

7/23/2014
CHARLESTON, W.Va. , July 23, 2014 /PRNewswire-iReach/ -- The Centers for Medicare & Medicaid Services (CMS) has awarded a new five-state Quality Innovation Network-Quality Improvement Organization (QIN-QIO) contract to a partnership led by the West Virginia Medical Institute (WVMI). Effective August 1, WVMI will launch Quality Insights Quality Innovation Network in West Virginia ,... [Comments]

Craig Mundie Joins RainTree Oncology Board of Directors

7/23/2014
SAN DIEGO , July 23, 2014  RT Oncology Services Corporation today announced that Craig Mundie has agreed to join its board of directors. Mr. Mundie is currently senior advisor to the CEO of Microsoft Corporation, where he works on strategic projects within the company and on technology strategy and policy. Previously, he was Microsoft's chief research and strategy office... [Comments]

Global Electrophysiology Ablation Catheters Market 2014-2018: Key Vendors are Boston Scientific, Johnson & Johnson, Medtronic and St. Jude Medical

7/23/2014
DUBLIN , July 23, 2014 Research and Markets   has announced the addition of the "Global Electrophysiology Ablation Catheters Market 2014-2018" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 Catheter ablation is a minimally invasive procedure used to remove or destroy faulty electrical pathways from sections of the heart that promote... [Comments]

New Analysis Finds $5.4 Billion In Annual Lost Savings From Strategies Geared Toward Delaying Generic Drug Entry

7/23/2014
WASHINGTON , July 23, 2014 /PRNewswire-iReach/ -- Use of Risk Evaluation and Mitigation Strategies (REMS) and other restricted access programs to delay generic market entry results in $5.4 billion in lost savings annually, according to a new survey and analysis by economic consulting firm Matrix Global Advisors (MGA). Logo - http://photos.prnewswire.com/prnh/20140723/129680 Required... [Comments]

(Date:7/23/2014)... Sergei Filippov (MIPT and Russian Quantum Center at ... Czech Republic, and the Institute of Physics in ... quantum entanglement of particles passing through an amplifier ... distances. Details are provided in an article published ... (see preprint). , Quantum entangled particles are considered ...
(Date:7/23/2014)... 2014 /PRNewswire-iReach/ -- Think Drinks are a neuroscience-backed drink ... term. They are the first functional focus beverage to ... an alternative to the temporary fix associated with energy ... July 29, 2014, with hopes to raise $50,000 over ... - http://photos.prnewswire.com/prnh/20140723/129697 Think Drinks ...
(Date:7/23/2014)... Columbia, MD (PRWEB) July 23, 2014 ... Station, an LC/MS amino acid analysis system developed ... analysis, the UF-Amino Station can analyze 38 amino ... , The UF-Amino Station achieves high-speed analysis utilizing ... spectrometer. The LCMS-2020 provides accurate analytical results even ...
(Date:7/23/2014)... July 23, 2014  Having the right people at ... to accelerating business growth and achieving clinical and operational ... (AHA) Leadership Summit, July 20-22, 2014, in ... hospital executives and healthcare experts discussing how partnerships have ... , President & Chief Executive Officer of Cape Regional ...
Breaking Biology Technology:Scientists find way to maintain quantum entanglement in amplified signals 2Scientists find way to maintain quantum entanglement in amplified signals 3Scientists find way to maintain quantum entanglement in amplified signals 4truBrain Neuroscientists To Launch More Effective, Healthier Alternative To Energy Drinks On Indiegogo 2Shimadzu's New UF-Amino Station Provides High-Speed, Multi-Component Analysis of Amino Acids in Food & Beverage and Pharmaceutical Testing 2MSC and Cape Regional Medical Center Partner to Improve Cost, Quality and Outcomes 2
... March 24 Cepheid (Nasdaq: CPHD ) ... speed of diagnosis of Mycobacterium tuberculosis (TB) ... disease.The new test technology, developed in partnership with Foundation ... of Medicine and Dentistry of New Jersey (UMDNJ), ...
... ViroPharma Incorporated (Nasdaq: VPHM ) ... transaction, $45 million principal amount or 18 percent ... 2017 for total consideration of approximately $21.2 million. ... million of principal debt are outstanding.As a result ...
... Safety & Satisfaction Record ChallengeCORONA DEL MAR, Calif., ... (ASA) functions much like the American Medical Association ... and JAMA , respectively) and express ... both groups function primarily (and legitimately) as political ...
Cached Biology Technology:Cepheid Announces New Diagnostic Technology to Aid World Efforts in Halting the Spread of Mycobacterium Tuberculosis (TB) 2Cepheid Announces New Diagnostic Technology to Aid World Efforts in Halting the Spread of Mycobacterium Tuberculosis (TB) 3Cepheid Announces New Diagnostic Technology to Aid World Efforts in Halting the Spread of Mycobacterium Tuberculosis (TB) 4Cepheid Announces New Diagnostic Technology to Aid World Efforts in Halting the Spread of Mycobacterium Tuberculosis (TB) 5Cepheid Announces New Diagnostic Technology to Aid World Efforts in Halting the Spread of Mycobacterium Tuberculosis (TB) 6ViroPharma Improves Financial Position Through Repurchase of $45 Million Principal Amount of Senior Convertible Notes 2ViroPharma Improves Financial Position Through Repurchase of $45 Million Principal Amount of Senior Convertible Notes 3ViroPharma Improves Financial Position Through Repurchase of $45 Million Principal Amount of Senior Convertible Notes 4American Society of Anesthesiologists Primary Agenda Displayed Says Dr. Barry Friedberg of Cosmetic Surgery Anesthesia 2
(Date:7/23/2014)... MINNEAPOLIS , July 23, 2014 ... they have added 14 new vendors so far ... Creekridge,s newest vendors are from both ... mid-size domestic organizations to large, well-known multi-national companies. ... Creekridge,s diversified suite of financing products including: standard ...
(Date:7/23/2014)... July 23, 2014 PositiveID Corp. (OTCQB: PSID), ... , is an emerging player in the bio-threat ... bio-threat detection and rapid medical testing. The Company,s ... Bio-agent Autonomous Networked Detector), was developed under contract ... Science & Technology directorate, and $30 million of ...
(Date:7/23/2014)... MEETING, Pa. , July 23, 2014 ... INO) today announced successful results from its ... VGX-3100 in women with biopsy-proven cervical intraepithelial ... (HPV) types 16 or 18. Treatment with ... regression of CIN2/3 to CIN1 or no ...
Breaking Medicine Technology:Creekridge Capital Signs Several New Vendor Partners 2PositiveID Analyst Inspection: Emerging Contender in BioThreat Detection - First Ever Revenue Guidance and Backlog Position Company for Increased Visibility and Traction - by SmallCapTraders.com 2Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 2Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 3Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 4Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 5
... April 18, 2011 Altitude Organic Corporation (Pinksheets: ... announced today that it has launched its third-party ... headquarters.  Visit the DoctorMMJ.com website ( www.DoctorMMJ.com ) ... and entirely legal medical marijuana evaluation in Arizona. ...
... MISSISSAUGA, Ontario, April 18, 2011 Valeant Pharmaceuticals International, ... filed a revised preliminary consent solicitation statement in which ... of proposed directors in connection with its previously announced ... Inc. (NASDAQ: CEPH).  Mr. Friedman will join the seven-member ...
Cached Medicine Technology:Altitude Organic Corporation Opens DoctorMMJ.com Physician Referral Service in Scottsdale, Arizona 2Altitude Organic Corporation Opens DoctorMMJ.com Physician Referral Service in Scottsdale, Arizona 3Valeant Pharmaceuticals Adds Corporate Governance Expert Abe Friedman to its Slate of Proposed Cephalon Directors 2Valeant Pharmaceuticals Adds Corporate Governance Expert Abe Friedman to its Slate of Proposed Cephalon Directors 3Valeant Pharmaceuticals Adds Corporate Governance Expert Abe Friedman to its Slate of Proposed Cephalon Directors 4